{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7ilaYKDA","lastupdate":"2022-09-13T00:00:00.000Z","update_date":"2022-09-13T00:00:00.000Z","lastModified":"Dec 22, 2021","active":1,"confidence_score":92,"confidence_score_reason":"not claimed","urlname":"cologuard","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$K87i3wZAMvXQMxyNg341VCrupHvXKBM0BhEy6nZwK8WULwngcLlLck","name":"Colospan","oneliner":"Technology for Colorectal Surgery","registrar":"514525971","website":"https://colospan.com/","careerspage":"","founded_month":12,"founded_year":2010,"formernames":["Cologuard"],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCGwTqu2jGBrH6cekUgWUEAA","facebook":"https://www.facebook.com/colospan","linkedin":"https://www.linkedin.com/company/68366723","instagram":""},"social":["https://www.youtube.com/channel/UCGwTqu2jGBrH6cekUgWUEAA","https://www.linkedin.com/company/68366723","https://www.facebook.com/colospan"],"flattenedsociallinks":"https://www.youtube.com/channel/UCGwTqu2jGBrH6cekUgWUEAA|https://www.linkedin.com/company/68366723|https://www.facebook.com/colospan","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":11,"patent":1,"raised":17000000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Colospan is a clinical-stage medical device company developing proprietary technology for colorectal surgery to prevent anastomotic leaks and divert colonic stomas. The companys lead product is a single-use, temporary intraluminal bypass device designed to reduce contact between fecal matter and the anastomotic site.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97297672518","country":null,"address":{"israeli":[{"id":"6bfb089f-c803-41ed-8d6f-f99cfad5ce78","city":"Kefar Sava","type":null,"address":"Atir Yeda Street 21, Kefar Sava, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"HwYPtLoTsOtOb13kMTQ2lvZXtLnr7ROaA3pDcHPWVs9jJVyVLJLjSV","city":"Cambridge","address":"125 Cambridgepark Dr, Cambridge, MA 02140, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"AOLSAkISEz45KEPQgGK2bOvj8BRQbdcYPHeOYRtNZ0a1ZSQ9OiRd7K","date":"Feb 21, 2022","link":"https://www.blechman.co.il/%D7%A9%D7%99%D7%AA%D7%95%D7%A3-%D7%A4%D7%A2%D7%95%D7%9C%D7%94-%D7%9E%D7%A0%D7%A6%D7%97-%D7%91%D7%99%D7%9F-%D7%91%D7%9C%D7%9B%D7%9E%D7%9F-%D7%9E%D7%A0%D7%A1-%D7%95%D7%A7%D7%95%D7%9C%D7%95%D7%A1%D7%A4/","source":"www.blechman.co.il","visible":1,"analysis":{"tags":"biotech","company":"קולוספן (ColoSpan)","layoffs":"","summary":"The Israeli biotech industry is experiencing tremendous growth. There are over a thousand biotech companies in Israel employing over forty thousand workers, and some are considered leaders in the world. The biotech companies face additional challenges related to strict regulations and long development processes. ColoSpan, an Israeli biotech company, has developed a device called CG-100 that prevents leaks in the digestive system. The device has been approved for marketing by the Ministry of Health and the European Union. ColoSpan partnered with Balcam Menas to produce the first set of product templates and ensure the highest quality and precision in the product design.","partners":"Balcam Menas","customers":"","investors":"","confidence":8,"key_topics":["ביוטק","קולוספן","CG-100","התקן","בלכמן מנס"],"date_of_event":"2016","valuation_amount":"","impact_on_company":"growth-positive","investment_amount":"","structured_issues":["Partners","Expand"],"acquisition_amount":"","structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2K7xwqGvjTWgnQWt8VDoo848UXTRSiAwmgNq88nSd3QwYDfvGVeQkT","news_summary":"שיתוף פעולה מנצח בין בלכמן מנס וקולוספן בתחום הביוטק","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1e4f3413-a004-4b35-a52f-b0e81a9486e6","date":"Dec 20, 2021","link":"https://www.einnews.com/pr_news/558792290/colospan-receives-8-2-million-from-the-european-innovation-council-for-its-novel-colorectal-surgery-device","source":"www.einnews.com","visible":1,"analysis":{"tags":"funding","company":"Colospan","layoffs":null,"summary":"Colospan, a company developing novel solutions for colorectal surgery, has been awarded €8.2 million ($9.3 million) from the European Innovation Council (EIC) as part of the EIC Accelerator program. The funding includes both a grant and equity financing. This funding is expected to have a growth-positive impact on the company. Colospan is one of 99 innovative start-ups and SMEs selected to receive funding from the European Commission to bring promising technologies to the market. The companys CG-100 device, an investigational device for colorectal cancer patients, is being developed and has received approval for use in the European Union, Israel, and under IDE in the USA.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Colorectal surgery","European Innovation Council","EIC Accelerator program","Grant and equity funding","CG-100 device"],"date_of_event":"December 20, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"€8.2 million ($9.3 million)","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"5j5ox1b24AWNn9G7djKLqYgZfuJTAEX3GYUGFUyDcftKVNvDdlUqzX","news_summary":"Colospan receives €8.2 million from the European Innovation Council for its novel colorectal surgery device","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"043847ae-44ba-4f89-b939-e460673ed1e0","date":"Oct 5, 2021","link":"https://www.prnewswire.com/news-releases/colospan-accelerates-fda-pivotal-trial-and-appoints-medtech-veteran-gregory-d-casciaro-to-the-board-of-directors-301393036.html?tc","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"appointment","company":"Colospan","layoffs":null,"summary":"Colospan, a medical device company specializing in colorectal surgery, has announced the appointment of Gregory D. Casciaro to its board of directors. Casciaro brings four decades of experience in the medtech industry and a track record of leading successful companies. Colospans CEO and Founder, Boaz Assaf, expressed excitement about Casciaros appointment and believes he will play a crucial role in shaping the companys future. Casciaro himself praised Colospans innovative product and expressed his enthusiasm for joining the board to improve patient lives and impact healthcare economics. Colospan is focused on addressing the challenges of anastomotic leaks in colorectal surgery and is currently conducting a multi-center randomized trial. The companys CG-100 product is not yet approved for sale in the United States. For more information, visit Colospans website.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["appointment","board of directors","medical device","colorectal surgery","novel solution"],"date_of_event":"October 5, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zm4sI6ZUicsALzEBmaHDTvCUjhGTZnj0Uxln7FK2FyScQF8G1h4ogQ","news_summary":"Colospan accelerates FDA pivotal trial and appoints medtech veteran, Gregory D. Casciaro, to the Board of Directors","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9be5c714-6a69-46a4-919e-45a4984ace6c","date":"Dec 9, 2020","link":"https://www.prnewswire.com/il/news-releases/henry-ford-hospital-first-in-the-us-to-test-novel-cg-100-intraluminal-device-in-patients-undergoing-colorectal-anastomosis-301189463.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical device","company":"Colospan Ltd.","layoffs":null,"summary":"Colospan Ltd. announced that Henry Ford Hospital in Detroit is the first in the U.S. to use the CG-100 bypass device in an investigational procedure for rectal cancer patients. The device aims to reduce the need for a diverting stoma and its related complications. Henry Ford Hospital is one of 12 sites nationwide participating in the clinical trial. Colorectal surgery often involves creating a stoma to divert waste from the bowel, but living with a stoma can be uncomfortable. The CG-100 device offers the potential for a more comfortable recovery and improved quality of life for patients. Colospan Ltd. is a medical device company focused on developing solutions for colorectal surgery.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["CG-100 bypass device","rectal cancer patients","colorectal surgery","diverting stoma","clinical trial"],"date_of_event":"2020-12-09","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3DjJw2OSxMlsUAb3FT1HhlYk6F8uLH7rbBGXEkaEUXevtW05G9THZz","news_summary":"Henry Ford Hospital First in the U.S. to Test Novel CG-100 Intraluminal Device in patients undergoing colorectal anastomosis","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"94d514ee-a1fd-40b8-8a01-586f5e5561cd","date":"Jan 20, 2020","link":"https://www.hospimedica.com/surgical-techniques/articles/294780580/gastrointestinal-bypass-device-offers-an-alternative-to-diverting-stoma.html","source":"www.hospimedica.com","visible":1,"analysis":{"tags":"medical device","company":"Colospan","layoffs":null,"summary":"Colospan, a medical device company based in Kfar Saba, Israel, has developed a novel temporary intraluminal bypass device called CG-100. The device is designed to reduce the rate of diverting stoma and related complications in patients undergoing gastrointestinal resection procedures. It diverts fecal material from contacting the anastomotic site during the initial healing period. The CG-100 has received approval from the European Community and an investigational device exemption from the U.S. Food and Drug Administration. Colospan plans to conduct a prospective, randomized pivotal study to bring the device closer to the market and improve patient outcomes. The device offers a short-term alternative to diverting stomas, which can cause significant complications and require a second procedure for closure.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["intraluminal bypass device","diverting stoma","gastrointestinal resection procedures","anastomotic leakage","temporary diversion solution"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7o9mUOiQEQaOpMMpVFqZfhpHmDDOf7qc59bEiLjWZGu6kxq6nelDvU","news_summary":"Gastrointestinal Bypass Device Offers an Alternative to Diverting Stoma","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"6de6879a-8d9d-40ac-996b-944c348c387b","date":"Jan 8, 2020","link":"https://www.prnewswire.com/news-releases/colospan-announces-fda-approval-of-ide-for-intraluminal-bypass-device--an-alternative-approach-to-diverting-stoma-300983455.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical device","company":"Colospan","layoffs":null,"summary":"Colospan, a medical device company specializing in solutions for colorectal surgery, has received FDA approval for its investigational device exemption (IDE) application. The approval allows the company to launch a pivotal study for its CG-100 device, which is designed to reduce diverting stoma rates in patients undergoing gastrointestinal resection procedures. The CG-100 is an alternative approach to diverting stoma and offers a shorter deployment time and easier removal compared to traditional methods. Colospan plans to conduct the study at leading medical centers in the US and Europe to evaluate the devices safety and efficacy. The approval marks a significant milestone for Colospan as it progresses in the clinical development of its technology.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["FDA approval","CG-100","colorectal surgery","pivotal study","diverting stoma"],"date_of_event":"2020-01-08","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"5VZUMTdMv8fHtLotPtQOZEDtm1lAExvomItVzh3rh22419N8S0Ia6Z","news_summary":"Colospan Announces FDA Approval of IDE for Intraluminal Bypass Device - an Alternative Approach to Diverting Stoma","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"53acdb09-9bfb-493e-8761-0457f475123e","date":"Sep 27, 2017","link":"http://www.globes.co.il/en/article-clinical-leakage-prevention-co-colospan-raises-77m-1001206421","source":"www.globes.co.il","visible":1,"analysis":{"tags":"medical, medicine","company":"Colospan","layoffs":null,"summary":"Colospan, a company developing a sleeve for protecting against intestinal leakage after a colectomy, has completed a $7.7 million financing round led by Triventures fund. The companys product is a silicon sleeve that prevents leakage in the intestine after surgery. The financing round included participation from existing investors Clal Biotechnology, Docor, and Amit Technion. Colospan has CE certification for marketing its products in Europe and is planning a limited launch in Europe in 2018. The company is also conducting a trial with 100 patients to obtain approval from the US Food and Drug Administration (FDA).","partners":null,"customers":null,"investors":"Triventures fund, Clal Biotechnology, Docor, Amit Technion","confidence":8,"key_topics":["Colospan","financing round","sleeve for protecting against intestinal leakage","Triventures fund","previous investors"],"date_of_event":"September 27, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$7.7 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"qxH9pEHeuT0YXcLWUq84mTIwwDOjviiSRI0FArtpN4x80WNfawlM0E","news_summary":"Clinical leakage prevention co Colospan raises $7.7m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":7,"techcommunityinvolvement":null,"mediagallery":[{"id":"457c4bc1-3890-4f66-9b66-64cc32c652f8","timestamp":"2018-07-26 11:07:03.000000","resources_type":2,"resources_title":"Colospan","resources_file_name":"klGRMcJjRSQ","alt":"Colospan logo","imageurl":"https://img.youtube.com/vi/klGRMcJjRSQ/0.jpg","url":"http://youtu.be/klGRMcJjRSQ"},{"id":"056305bb-f6ef-4239-9e73-d4fd44e337be","timestamp":"2017-12-19 15:08:23.000000","resources_type":1,"resources_title":"","resources_file_name":"$xJrpry5TzU1scsPzbhFq1fKWJP8DRlCCVHx14V8gdwBaaOcWZwut9C","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$xJrpry5TzU1scsPzbhFq1fKWJP8DRlCCVHx14V8gdwBaaOcWZwut9C","url":"https://storage.googleapis.com/clean-finder-353810/$xJrpry5TzU1scsPzbhFq1fKWJP8DRlCCVHx14V8gdwBaaOcWZwut9C"}],"tags":["gastroenterology","surgery","medical-devices","surgical-instruments","surgeons","prevention","treatments","cancer","colonoscopy","hospitals"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["CG-100"],"geomarkets":["Europe","United States"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":6,"lastfunding":"$9.3M","totalrounds":3,"fundingstage":"Seed","totalfunding":"$17M","publicinvestors":6,"lastpublicfunding":9300000,"totalpublicrounds":3,"totalpublicfunding":17000000},"team":[{"name":"Michal Geva","email":"michalg@triventures.net","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4IHs5pwLDA","bounced":true,"claimed":0,"founder":0,"urlname":"michal-geva-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgoY3KzQoM","position":"Board Member","last_name":"Geva","claimtoken":"37f4a5f6e5b169c2af8712ca6b76e2413765d68563ac747966092be2bc46b0fd","first_name":"Michal","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/michal-geva-90b3465/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-06-23 14:11:05.000000","initials":"MG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Boaz Assaf","email":"boaz.assaf@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwNLskIoKDA","bounced":false,"claimed":1,"founder":1,"urlname":"boaz-assaf-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA8bLKvwkM","position":"Founder & CEO","last_name":"Assaf","claimtoken":"5d8e7a0e4820ae13eeff75942a02406e371abfed20c4cb665c64237466ea154f","first_name":"Boaz","picturekey":"$XFWpfQHVrtd4UWVBUsyAA1z5Ucph6LGmXMkcGzbFeSTsjOpnw0dwMY","claimeddate":"2016-08-08","linkedinurl":"https://www.linkedin.com/in/boaz-assaf-a856642/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2016-08-07 06:30:28.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$XFWpfQHVrtd4UWVBUsyAA1z5Ucph6LGmXMkcGzbFeSTsjOpnw0dwMY","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Tamir Peleg","email":"tamir@colospan.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoOWSnMELDA","bounced":false,"claimed":0,"founder":0,"urlname":"tamir-peleg","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgpa21zgsM","position":"Sales & Marketing Manager","last_name":"Peleg","claimtoken":"H3b5uBRqDi54j2oNP1eGXAu1UIfMGjjTo1j3Ro8ksIfSRAAOWIulKK","first_name":"Tamir","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/tamir-peleg-86602a73/","unsubscribed":false,"is_activeuser":1,"additionalemail":"tamir@cologuard.co.il","claimedemaildate":"2022-09-13 14:39:12.000000","initials":"TP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2019-12-18T00:00:00.000Z","crunchbaseid":"colospan","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":null,"creator_email":null,"createdate":"2015-02-03T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":"Sharon Shapira","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDIt9_UCAw","date":"Dec 2021","amount":"$9.3M","source":"https://www.einnews.com/pr_news/558792290/colospan-receives-8-2-million-from-the-european-innovation-council-for-its-novel-colorectal-surgery-device","eventtype":"FundingRoundEvent","investment":[{"name":"European Innovation Council (EIC)","type":"Other","amount":0,"hidden":false,"country":"Unknown location","fullurl":"/company_page/european-innovation-council-eic","logokey":null,"tagline":"European Innovation Council (EIC) ","urlname":"/company_page/european-innovation-council-eic","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODKhviGCQw","fundingtype":"Other","leadpartner":null,"investmentid":"6c80ee6d-ae15-43c7-bb28-4f31bc393d95","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":9300000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCko8SbCww","date":"Sep 2017","amount":"$7.7M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Anatomy Medical Technology Fund","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/anatomy-medical-technology-fund","logokey":null,"tagline":"","urlname":"/investor_page/anatomy-medical-technology-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8IGECgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3ceccc34-17f7-40aa-8354-4ee5badcb0fb","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Docor International Management","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/docor","logokey":"$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","tagline":null,"urlname":"/investor_page/docor","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMnYj5YKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5bc46329-a8e0-4c33-83ae-e4b96d5c1743","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","leadcaption":"","followupcaption":""},{"name":"AMIT-Technion ( The Alfred Mann Institute)","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/amit-technion-the-alfred-mann-institute","logokey":"$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","tagline":"Development & Commercialization of Biomedical Innovations Conceived by Technion Researcher","urlname":"/company_page/amit-technion-the-alfred-mann-institute","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODUpcX1Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"80138edb-8b84-45fd-a40a-7932e2c15f3f","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","leadcaption":"","followupcaption":""},{"name":"Triventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/triventures","logokey":"$dzsYbSrKJgvPvZBbbhpoltTv6B2WRBi4fCaQ7HOyP0c9HhBg7OFO8N","tagline":null,"urlname":"/investor_page/triventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJHdj50LDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"b0187685-b392-41eb-8d5b-326ea2c7014b","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dzsYbSrKJgvPvZBbbhpoltTv6B2WRBi4fCaQ7HOyP0c9HhBg7OFO8N","leadcaption":"","followupcaption":""},{"name":"Clal Biotechnology Industries (CBI)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/cbi","logokey":"$fJl2RfhlVYviq9T0pSOI3rKMQTrLfwIf7Co69YLOBIKRfoeftdbWGk","tagline":null,"urlname":"/investor_page/cbi","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKG0pYwKDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"c5a2001c-8cd6-49ab-b71b-b12e9a5a8499","fundingsubtype":"Corporate VC","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$fJl2RfhlVYviq9T0pSOI3rKMQTrLfwIf7Co69YLOBIKRfoeftdbWGk","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmt3HCgw","date":"Mar 2017","amount":"Undisclosed","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"EU Horizon 2020","type":"Other","amount":0,"hidden":false,"country":"Belgium","fullurl":"/company_page/eu-horizon-2020","logokey":"$Y11JsXnB1FT2S0h1lyXUQMAhH6bM0g2tSIdWQAjTFxivAoweBwRj4g","tagline":"","urlname":"/company_page/eu-horizon-2020","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7vSzCgw","fundingtype":"Other","leadpartner":null,"investmentid":"3be1693a-0d8f-458e-8b10-7fe7dd6af8e0","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Y11JsXnB1FT2S0h1lyXUQMAhH6bM0g2tSIdWQAjTFxivAoweBwRj4g","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":1,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"12/2010","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Colospan","logourl":"https://storage.googleapis.com/clean-finder-353810/$K87i3wZAMvXQMxyNg341VCrupHvXKBM0BhEy6nZwK8WULwngcLlLck","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$K87i3wZAMvXQMxyNg341VCrupHvXKBM0BhEy6nZwK8WULwngcLlLck","seoabout":"Colospan is a clinical-stage medical device company developing proprietary technology for colorectal surgery to prevent anastomotic leaks and divert coloni...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":[],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDIt9_UCAw","date":"Dec 2021","amount":"$9.3M","source":"https://www.einnews.com/pr_news/558792290/colospan-receives-8-2-million-from-the-european-innovation-council-for-its-novel-colorectal-surgery-device","eventtype":"FundingRoundEvent","investment":[{"name":"European Innovation Council (EIC)","type":"Other","amount":0,"hidden":false,"country":"Unknown location","fullurl":"/company_page/european-innovation-council-eic","logokey":null,"tagline":"European Innovation Council (EIC) ","urlname":"/company_page/european-innovation-council-eic","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODKhviGCQw","fundingtype":"Other","leadpartner":null,"investmentid":"6c80ee6d-ae15-43c7-bb28-4f31bc393d95","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/startups-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":9300000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCko8SbCww","date":"Sep 2017","amount":"$7.7M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Anatomy Medical Technology Fund","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/anatomy-medical-technology-fund","logokey":null,"tagline":"","urlname":"/investor_page/anatomy-medical-technology-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk8IGECgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3ceccc34-17f7-40aa-8354-4ee5badcb0fb","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Docor International Management","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/docor","logokey":"$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","tagline":null,"urlname":"/investor_page/docor","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMnYj5YKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5bc46329-a8e0-4c33-83ae-e4b96d5c1743","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","leadcaption":"","followupcaption":""},{"name":"AMIT-Technion ( The Alfred Mann Institute)","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/amit-technion-the-alfred-mann-institute","logokey":"$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","tagline":"Development & Commercialization of Biomedical Innovations Conceived by Technion Researcher","urlname":"/company_page/amit-technion-the-alfred-mann-institute","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODUpcX1Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"80138edb-8b84-45fd-a40a-7932e2c15f3f","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","leadcaption":"","followupcaption":""},{"name":"Triventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/triventures","logokey":"$dzsYbSrKJgvPvZBbbhpoltTv6B2WRBi4fCaQ7HOyP0c9HhBg7OFO8N","tagline":null,"urlname":"/investor_page/triventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJHdj50LDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"b0187685-b392-41eb-8d5b-326ea2c7014b","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dzsYbSrKJgvPvZBbbhpoltTv6B2WRBi4fCaQ7HOyP0c9HhBg7OFO8N","leadcaption":"","followupcaption":""},{"name":"Clal Biotechnology Industries (CBI)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/cbi","logokey":"$fJl2RfhlVYviq9T0pSOI3rKMQTrLfwIf7Co69YLOBIKRfoeftdbWGk","tagline":null,"urlname":"/investor_page/cbi","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKG0pYwKDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"c5a2001c-8cd6-49ab-b71b-b12e9a5a8499","fundingsubtype":"Corporate VC","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$fJl2RfhlVYviq9T0pSOI3rKMQTrLfwIf7Co69YLOBIKRfoeftdbWGk","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmt3HCgw","date":"Mar 2017","amount":"Undisclosed","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"EU Horizon 2020","type":"Other","amount":0,"hidden":false,"country":"Belgium","fullurl":"/company_page/eu-horizon-2020","logokey":"$Y11JsXnB1FT2S0h1lyXUQMAhH6bM0g2tSIdWQAjTFxivAoweBwRj4g","tagline":"","urlname":"/company_page/eu-horizon-2020","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7vSzCgw","fundingtype":"Other","leadpartner":null,"investmentid":"3be1693a-0d8f-458e-8b10-7fe7dd6af8e0","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Y11JsXnB1FT2S0h1lyXUQMAhH6bM0g2tSIdWQAjTFxivAoweBwRj4g","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":1,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}